Endoscopic Lung Volume Reduction: An Expert Panel Recommendation – Update 2019
Endoscopic lung volume reduction (ELVR) therapies are gaining prominence as a treatment option with guideline recommendations by COPD GOLD and NICE and the recent FDA approval for endobronchial valves. The transition from an experiment-based therapy only to clinical care comes with new challenges. A...
Saved in:
| Published in | Respiration Vol. 97; no. 6; pp. 548 - 557 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Basel, Switzerland
01.01.2019
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0025-7931 1423-0356 1423-0356 |
| DOI | 10.1159/000496122 |
Cover
| Abstract | Endoscopic lung volume reduction (ELVR) therapies are gaining prominence as a treatment option with guideline recommendations by COPD GOLD and NICE and the recent FDA approval for endobronchial valves. The transition from an experiment-based therapy only to clinical care comes with new challenges. A significant volume of evidence-based data has been published; all data demonstrate consistent improvements in several aspects of patient outcomes. Patients suffering from severe air trapping and thoracic hyperinflation seem to benefit the most from ELVR. In addition to lung function, baseline assessment should ideally include cardiopulmonary exercise testing, high-resolution computer tomography scan, perfusion scintigraphy, and echocardiography. This expert ELVR statement updates best practice recommendations from 2017 regarding patient selection and utilization of these various techniques for treating patients with advanced emphysema. |
|---|---|
| AbstractList | Endoscopic lung volume reduction (ELVR) therapies are gaining prominence as a treatment option with guideline recommendations by COPD GOLD and NICE and the recent FDA approval for endobronchial valves. The transition from an experiment-based therapy only to clinical care comes with new challenges. A significant volume of evidence-based data has been published; all data demonstrate consistent improvements in several aspects of patient outcomes. Patients suffering from severe air trapping and thoracic hyperinflation seem to benefit the most from ELVR. In addition to lung function, baseline assessment should ideally include cardiopulmonary exercise testing, high-resolution computer tomography scan, perfusion scintigraphy, and echocardiography. This expert ELVR statement updates best practice recommendations from 2017 regarding patient selection and utilization of these various techniques for treating patients with advanced emphysema. Endoscopic lung volume reduction (ELVR) therapies are gaining prominence as a treatment option with guideline recommendations by COPD GOLD and NICE and the recent FDA approval for endobronchial valves. The transition from an experiment-based therapy only to clinical care comes with new challenges. A significant volume of evidence-based data has been published; all data demonstrate consistent improvements in several aspects of patient outcomes. Patients suffering from severe air trapping and thoracic hyperinflation seem to benefit the most from ELVR. In addition to lung function, baseline assessment should ideally include cardiopulmonary exercise testing, high-resolution computer tomography scan, perfusion scintigraphy, and echocardiography. This expert ELVR statement updates best practice recommendations from 2017 regarding patient selection and utilization of these various techniques for treating patients with advanced emphysema.Endoscopic lung volume reduction (ELVR) therapies are gaining prominence as a treatment option with guideline recommendations by COPD GOLD and NICE and the recent FDA approval for endobronchial valves. The transition from an experiment-based therapy only to clinical care comes with new challenges. A significant volume of evidence-based data has been published; all data demonstrate consistent improvements in several aspects of patient outcomes. Patients suffering from severe air trapping and thoracic hyperinflation seem to benefit the most from ELVR. In addition to lung function, baseline assessment should ideally include cardiopulmonary exercise testing, high-resolution computer tomography scan, perfusion scintigraphy, and echocardiography. This expert ELVR statement updates best practice recommendations from 2017 regarding patient selection and utilization of these various techniques for treating patients with advanced emphysema. |
| Author | Slebos, Dirk-Jan Criner, Gerard J. Valipour, Arschang Herth, Felix J.F. Sciurba, Frank Shah, Pallav L. |
| Author_xml | – sequence: 1 givenname: Felix J.F. surname: Herth fullname: Herth, Felix J.F. email: felix.herth@med.uni-heidelberg.de – sequence: 2 givenname: Dirk-Jan surname: Slebos fullname: Slebos, Dirk-Jan – sequence: 3 givenname: Gerard J. surname: Criner fullname: Criner, Gerard J. – sequence: 4 givenname: Arschang surname: Valipour fullname: Valipour, Arschang – sequence: 5 givenname: Frank surname: Sciurba fullname: Sciurba, Frank – sequence: 6 givenname: Pallav L. orcidid: 0000-0002-9052-4638 surname: Shah fullname: Shah, Pallav L. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30836374$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkEtLxDAUhYMoOj4W7kUCbnRRzU2atnE3yPiAAYfxsS1pkkq1bWrSgu78D_5Df4kdZ-xC3NzD5XzncjnbaL22tUFoH8gpABdnhJBQREDpGhpBSFlAGI_W0YgQyoNYMNhC294_EwI8Segm2mIkYRGLwxGaTWptvbJNofC0q5_woy27yuC50Z1qC1uf43GNJ2-NcS2eydqUvaVsVZlay4WPvz4-8UPTLwZTAmIXbeSy9GZvpTvo4XJyf3EdTG-vbi7G00CFjLeBjpURUc4JySDPKGgQLAImNFc8giQksQSWyJgZEIYp6FVGjErIudRCZGwHHS_vNs6-dsa3aVV4Zcqy_9F2PqWQJFz0I-rRwxXaZZXRaeOKSrr39LeFHjhZAspZ753JBwRIumg4HRru2bM_rCranyZaJ4vy38TBMvEi3ZNxw-3BPvrXnk_ulkTa6Jx9A7_ujzk |
| CitedBy_id | crossref_primary_10_1183_16000617_0004_2023 crossref_primary_10_1111_resp_14338 crossref_primary_10_1111_resp_14734 crossref_primary_10_1148_ryct_220273 crossref_primary_10_1183_23120541_00672_2021 crossref_primary_10_1097_RTI_0000000000000549 crossref_primary_10_1159_000515744 crossref_primary_10_1097_MD_0000000000034434 crossref_primary_10_2147_COPD_S240848 crossref_primary_10_2169_internalmedicine_2250_23 crossref_primary_10_1159_000505428 crossref_primary_10_1093_icvts_ivae094 crossref_primary_10_1111_imj_16404 crossref_primary_10_1111_resp_14371 crossref_primary_10_1183_23120541_00116_2020 crossref_primary_10_3390_jcm13082354 crossref_primary_10_1183_16000617_0142_2021 crossref_primary_10_1055_a_1114_0709 crossref_primary_10_1159_000502100 crossref_primary_10_3390_jcm13216471 crossref_primary_10_1164_rccm_201907_1292SO crossref_primary_10_1159_000540780 crossref_primary_10_1183_23120541_00155_2023 crossref_primary_10_1183_23120541_00190_2023 crossref_primary_10_1183_20734735_0186_2019 crossref_primary_10_1097_LBR_0000000000000634 crossref_primary_10_3390_jcm11133680 crossref_primary_10_4037_ccn2024247 crossref_primary_10_1080_15412555_2025_2468328 crossref_primary_10_1016_j_mayocpiqo_2020_09_009 crossref_primary_10_1097_MCP_0000000000000840 crossref_primary_10_1164_rccm_202201_0214OC crossref_primary_10_1016_j_lfs_2024_122718 crossref_primary_10_1164_rccm_201902_0383OC crossref_primary_10_1183_23120541_00449_2020 crossref_primary_10_1159_000517598 crossref_primary_10_3390_life13041036 crossref_primary_10_1183_23120541_00191_2021 crossref_primary_10_1097_SPC_0000000000000682 crossref_primary_10_1159_000502310 crossref_primary_10_1183_23120541_00492_2021 crossref_primary_10_1055_s_0040_1702192 crossref_primary_10_1097_CM9_0000000000002042 crossref_primary_10_33667_2078_5631_2019_3_29_404__8_15 crossref_primary_10_1055_s_0042_1747938 crossref_primary_10_1097_LBR_0000000000000762 crossref_primary_10_1111_resp_13835 crossref_primary_10_1159_000514319 crossref_primary_10_1007_s00408_020_00368_9 crossref_primary_10_2147_COPD_S442380 crossref_primary_10_1016_j_ejrad_2021_109561 crossref_primary_10_1016_j_chest_2020_12_007 crossref_primary_10_1007_s10405_021_00413_1 crossref_primary_10_1183_23120541_00735_2023 crossref_primary_10_1183_23120541_00258_2021 crossref_primary_10_1016_j_rmr_2022_12_008 crossref_primary_10_1016_j_yacr_2022_06_001 crossref_primary_10_1159_000524996 crossref_primary_10_1183_23120541_00322_2019 crossref_primary_10_1007_s11547_024_01883_y crossref_primary_10_1016_j_rmed_2024_107639 crossref_primary_10_1007_s15033_022_3431_y crossref_primary_10_1111_resp_13903 crossref_primary_10_1183_16000617_0029_2020 crossref_primary_10_1159_000511599 crossref_primary_10_1148_rg_240156 crossref_primary_10_1164_rccm_202102_0260OC crossref_primary_10_1016_j_mayocp_2023_05_001 crossref_primary_10_1159_000516326 crossref_primary_10_1159_000506522 crossref_primary_10_1007_s13665_020_00266_8 crossref_primary_10_1016_j_arbres_2024_04_012 crossref_primary_10_2147_COPD_S307829 crossref_primary_10_1007_s10405_019_00278_5 crossref_primary_10_1007_s13665_019_00236_9 crossref_primary_10_5694_mja2_51218 crossref_primary_10_1007_s00408_019_00265_w crossref_primary_10_2147_COPD_S361256 |
| Cites_doi | 10.1159/000360642 10.1159/000479379 10.2147/COPD.S106439 10.1159/000368369 10.1001/jama.2012.12656 10.1159/000448761 10.1016/S2213-2600(16)00045-X 10.1183/09031936.00015312 10.1164/rccm.201803-0590OC 10.1152/physrev.00025.2015 10.1016/S0140-6736(15)60001-0 10.1159/000360641 10.1159/000492274 10.1159/000448849 10.1164/rccm.201210-1843CI 10.1001/jama.2016.6261 10.1164/rccm.201610-1993LE 10.1159/000490733 10.1159/000322649 10.1183/09031936.06.00124605 10.1016/S2213-2600(13)70047-X 10.1164/rccm.201701-0218PP 10.1055/s-0035-1556064 10.1164/rccm.201703-0451PP 10.1016/S2213-2600(16)30199-0 10.1056/NEJMoa0900928 10.1164/rccm.201607-1383OC 10.1159/000431384 10.2147/COPD.S117890 10.1183/09031936.00161611 10.1159/000362522 10.1159/000434685 10.1164/rccm.201604-0852LE 10.1159/000444090 10.2147/COPD.S117655 10.1183/09031936.00205614 10.1056/NEJMra1201534 10.1371/journal.pone.0042227 10.1159/000477258 10.1001/jama.2015.17821 10.1378/chest.12-0421 10.1159/000452629 |
| ContentType | Journal Article |
| Copyright | 2019 S. Karger AG, Basel 2019 S. Karger AG, Basel. |
| Copyright_xml | – notice: 2019 S. Karger AG, Basel – notice: 2019 S. Karger AG, Basel. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1159/000496122 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1423-0356 |
| EndPage | 557 |
| ExternalDocumentID | 30836374 10_1159_000496122 496122 |
| Genre | Journal Article |
| GroupedDBID | --- .GJ .XZ 0R~ 0~5 0~B 123 29P 30W 327 34G 36B 39C 3O. 3V. 4.4 53G 5RE 7RQ 7RV 7X7 88E 8AO 8FI 8FJ 8G5 8UI AAWTL AAYIC ABJNI ABPAZ ABUWG ACGFS ACPSR ADAGL ADBBV AENEX AEYAO AFJJK AFKRA AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS APPQY AZPMC AZQEC BENPR BKEYQ BPHCQ BVXVI C45 CAG CCPQU COF CS3 CYUIP DU5 DWQXO E0A EBS EJD EMB EMOBN EX3 F5P FB. FYUFA GNUQQ GUQSH HMCUK HZ~ IAO IHR IHW IY7 KUZGX L7B M1P M2O N9A NAPCQ O1H O9- OVD PQQKQ PROAC PSQYO RIG RKO RXVBD SV3 TEORI UJ6 UKHRP WOW ZGI ZXP AAYXX ABBTS ABWCG ACQXL AFSIO AHFRZ CITATION ITC PHGZM PHGZT PJZUB PPXIY NPM 7X8 |
| ID | FETCH-LOGICAL-c435t-d7ce96f500b1fb21d1936139d5c5618407a138a73e19e3c13e1a632a1f5ad99b3 |
| ISSN | 0025-7931 1423-0356 |
| IngestDate | Thu Sep 04 19:01:57 EDT 2025 Wed Feb 19 02:30:40 EST 2025 Thu Apr 24 23:01:33 EDT 2025 Tue Aug 05 12:09:38 EDT 2025 Thu Aug 29 12:04:40 EDT 2024 Thu Sep 05 17:58:24 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | Bronchoscopy Chronic obstructive pulmonary disease Lung volume reduction Hyperinflation Emphysema Expert statement |
| Language | English |
| License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. https://www.karger.com/Services/SiteLicenses 2019 S. Karger AG, Basel. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c435t-d7ce96f500b1fb21d1936139d5c5618407a138a73e19e3c13e1a632a1f5ad99b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9052-4638 0000-0001-9555-3422 0000-0002-7638-2506 |
| OpenAccessLink | https://karger.com/res/article-pdf/97/6/548/3522404/000496122.pdf |
| PMID | 30836374 |
| PQID | 2188591886 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | pubmed_primary_30836374 proquest_miscellaneous_2188591886 crossref_citationtrail_10_1159_000496122 crossref_primary_10_1159_000496122 karger_primary_496122 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-01-01 |
| PublicationDateYYYYMMDD | 2019-01-01 |
| PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Basel, Switzerland |
| PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland |
| PublicationTitle | Respiration |
| PublicationTitleAlternate | Respiration |
| PublicationYear | 2019 |
| References | Excellence NI. Endobronchial valve insertion to reduce lung volume in emphysema.nice.org.uk/guidance/ipg600, 2017. Darwiche K, Karpf-Wissel R, Eisenmann S, Aigner C, Welter S, Zarogoulidis P, et al.. Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 Patients. Respiration. 2016;92(6):414–9. 10.1159/000452629278386951423-0356 Slebos DJ, Hartman JE, Klooster K, Blaas S, Deslee G, Gesierich W, et al.. Bronchoscopic Coil Treatment for Patients with Severe Emphysema: A Meta-Analysis. Respiration. 2015;90(2):136–45. 10.1159/000431384261123801423-0356 Gompelmann D, Lim HJ, Eberhardt R, Gerovasili V, Herth FJ, Heussel CP, et al.. Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema. Int J Chron Obstruct Pulmon Dis. 2016Aug;11:1767–73. 10.2147/COPD.S106439275360881176-9106 Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, et al.; RENEW Study Research Group. Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial. JAMA. 2016May;315(20):2178–89. 10.1001/jama.2016.6261271798490098-7484 Herth FJ, Slebos DJ, Rabe KF, Shah PL. Endoscopic Lung Volume Reduction: An Expert Panel Recommendation. Respiration. 2016;91(3):241–50. 10.1159/000444090269108451423-0356 Shah PL, Gompelmann D, Valipour A, McNulty WH, Eberhardt R, Grah C, et al.. Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results. Lancet Respir Med. 2016Sep;4(9):e44–5. 10.1016/S2213-2600(16)30199-0274513452213-2600 Mets OM, de Jong PA, Prokop M. Computed tomographic screening for lung cancer: an opportunity to evaluate other diseases. JAMA. 2012Oct;308(14):1433–4. 10.1001/jama.2012.12656230473540098-7484 Welling JB, Hartman JE, Ten Hacken NH, Franz I, Charbonnier JP, van Rikxoort EM, et al.. Chartis Measurement of Collateral Ventilation: Conscious Sedation versus General Anesthesia - A Retrospective Comparison. Respiration. 2018;96(5):480–7. 10.1159/000490733301147071423-0356 Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, et al.; RESET trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med. 2013May;1(3):233–40. 10.1016/S2213-2600(13)70047-X244291292213-2600 Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006Sep;28(3):523–32. 10.1183/09031936.06.00124605166116540903-1936 Hogg JC, Paré PD, Hackett TL. The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease. Physiol Rev. 2017Apr;97(2):529–52. 10.1152/physrev.00025.2015281514250031-9333 Klooster K, Hartman JE, Ten Hacken NH, Slebos DJ. Improved Predictors of Survival after Endobronchial Valve Treatment in Patients with Severe Emphysema. Am J Respir Crit Care Med. 2017May;195(9):1272–4. 10.1164/rccm.201610-1993LE284593161073-449X Garner J, Kemp SV, Toma TP, Hansell DM, Polkey MI, Shah PL, et al.. Survival after Endobronchial Valve Placement for Emphysema: A 10-Year Follow-up Study. Am J Respir Crit Care Med. 2016Aug;194(4):519–21. 10.1164/rccm.201604-0852LE275254621073-449X Klooster K, Ten Hacken NH, Franz I, Kerstjens HA, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration. 2014;88(2):116–25. 10.1159/000362522249029991423-0356 Eberhardt R, Gerovasili V, Kontogianni K, Gompelmann D, Ehlken N, Herth FJ, et al.. Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration. 2015;89(1):41–8. 10.1159/000368369255022351423-0356 Gompelmann D, Herth FJ, Slebos DJ, Valipour A, Ernst A, Criner GJ, et al.. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration. 2014;87(6):485–91. 10.1159/000360641248008141423-0356 Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013Feb;187(3):228–37. 10.1164/rccm.201210-1843CI232042541073-449X Herth FJ, Noppen M, Valipour A, Leroy S, Vergnon JM, Ficker JH, et al.; International VENT Study Group. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012Jun;39(6):1334–42. 10.1183/09031936.00161611222825520903-1936 Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH, et al.; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010Sep;363(13):1233–44. 10.1056/NEJMoa0900928208605050028-4793 The Global Strategy for Diagnosis. Management and Prevention of COPD, updated2019. https://goldcopd.org/gold-reports Herth FJ, Gompelmann D, Stanzel F, Bonnet R, Behr J, Schmidt B, et al.. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal®). Respiration. 2011;82(1):36–45. 10.1159/000322649212285451423-0356 Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest. 2012Nov;142(5):1111–7. 10.1378/chest.12-0421227222330012-3692 Kontogianni K, Gerovasili V, Gompelmann D, Schuhmann M, Hoffmann H, Heussel CP, et al.. Coil therapy for patients with severe emphysema and bilateral incomplete fissures - effectiveness and complications after 1-year follow-up: a single-center experience. Int J Chron Obstruct Pulmon Dis. 2017Jan;12:383–94. 10.2147/COPD.S117655281769541176-9106 Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013Aug;369(5):448–57. 10.1056/NEJMra1201534239024840028-4793 Wang G, S.l., Changhui W, Xinglin G, Faguang J, Huaping Y, Baohui H, Rui Z, Chengshui C, Liangan C, Chunxue B, Huahao S, Nanshan Z., Eur Respi J. The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results., 2018. 50: p. OA 1465. Criner GD, Voelker K, et al. Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial. Eur Respir J, 2018: p. OA 4928. van Geffen WH, Klooster K, Hartman JE, Ten Hacken NH, Kerstjens HA, Wolf RF, et al.. Pleural Adhesion Assessment as a Predictor for Pneumothorax after Endobronchial Valve Treatment. Respiration. 2017;94(2):224–31. 10.1159/000477258286370471423-0356 Li S, Wang G, Wang C, Gao X, Jin F, Yang H, Han B, Zhou R, Chen C, Chen L, Bai C, Shen H, Herth FJF, Zhong N. The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema. Respiration. DOI: 10.1159/000494327. Epub ahead of print. Criner GJ, et al.. A Multicenter RCT of Zephyr(R) Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE). Am J Respir Crit Care Med. 2018. 10.1164/rccm.201803-0590OC1073-449X Gompelmann D, B.N., Bischoff E, Kontogianni K, Schuhmann M, Hoffmann H, Heussel CP, Herth FJF, Eberhardt R, Survival after endoscopic valve therapy in patients with severe emphysema. Respiration, 2018(epub ahead). 10.1159/000492274 Herth FJ, Valipour A, Shah PL, Eberhardt R, Grah C, Egan J, et al.. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med. 2016Mar;4(3):185–93. 10.1016/S2213-2600(16)00045-X268993902213-2600 Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group. Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial. JAMA. 2016 Jan 12;315(2):175–84. Klooster K, ten Hacken NN, Slebos DJ. Endobronchial Valves for Emphysema. N Engl J Med. 2016Apr;374(14):1390.270502221533-4406 Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al.; Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017Mar;195(5):557–82. 10.1164/rccm.201701-0218PP281289701073-449X Valipour A, Slebos DJ, de Oliveira HG, Eberhardt R, Freitag L, Criner GJ, et al.. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema—potential mechanisms, treatment algorithm, and case examples. Respiration. 2014;87(6):513–21. 10.1159/000360642247772921423-0356 Trudzinski FC, Höink AJ, Leppert D, Fähndrich S, Wilkens H, Graeter TP, et al.. Endoscopic Lung Volume Reduction Using Endobronchial Valves in Patients with Severe Emphysema and Very Low FEV1. Respiration. 2016;92(4):258–65. 10.1159/000448761276037811423-0356 Herth FJ, Eberhardt R, Gompelmann D, Ficker JH, Wagner M, Ek L, et al.. Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. Eur Respir J. 2013Feb;41(2):302–8. 10.1183/09031936.00015312225560250903-1936 Marchetti N, Criner GJ. Surgical Approaches to Treating Emphysema: Lung Volume Reduction Surgery, Bullectomy, and Lung Transplantation. Semin Respir Crit Care Med. 2015Aug;36(4):592–608. 10.1055/s-0035-1556064262386441069-3424 Davey C, Zoumot Z, Jordan S, McNulty WH, Carr DH, Hind MD, et al.. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015Sep;386(9998):1066–73. 10.1016/S0140-6736(15)60001-0261164850140-6736 Labaki WW, Martinez CH, Martinez FJ, Galbán CJ, Ross BD, Was ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref42 ref41 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 ref40 |
| References_xml | – reference: Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013Feb;187(3):228–37. 10.1164/rccm.201210-1843CI232042541073-449X – reference: Sciurba FC, Criner GJ, Strange C, Shah PL, Michaud G, Connolly TA, et al.; RENEW Study Research Group. Effect of Endobronchial Coils vs Usual Care on Exercise Tolerance in Patients With Severe Emphysema: The RENEW Randomized Clinical Trial. JAMA. 2016May;315(20):2178–89. 10.1001/jama.2016.6261271798490098-7484 – reference: Trudzinski FC, Höink AJ, Leppert D, Fähndrich S, Wilkens H, Graeter TP, et al.. Endoscopic Lung Volume Reduction Using Endobronchial Valves in Patients with Severe Emphysema and Very Low FEV1. Respiration. 2016;92(4):258–65. 10.1159/000448761276037811423-0356 – reference: Gompelmann D, B.N., Bischoff E, Kontogianni K, Schuhmann M, Hoffmann H, Heussel CP, Herth FJF, Eberhardt R, Survival after endoscopic valve therapy in patients with severe emphysema. Respiration, 2018(epub ahead). 10.1159/000492274 – reference: Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al.; Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017Mar;195(5):557–82. 10.1164/rccm.201701-0218PP281289701073-449X – reference: Herth FJ, Slebos DJ, Criner GJ, Shah PL. Endoscopic Lung Volume Reduction: An Expert Panel Recommendation - Update 2017. Respiration. 2017;94(4):380–8. 10.1159/000479379288178211423-0356 – reference: Herth FJ, Gompelmann D, Stanzel F, Bonnet R, Behr J, Schmidt B, et al.. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal®). Respiration. 2011;82(1):36–45. 10.1159/000322649212285451423-0356 – reference: van Geffen WH, S.D., Herth FJ, Kemp SV, Weder W, Shah PL., Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis. Lancet Respir Med, 2018: p. accepted. – reference: Kramer MR, Refaely Y, Maimon N, Rosengarten D, Fruchter O. Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest. 2012Nov;142(5):1111–7. 10.1378/chest.12-0421227222330012-3692 – reference: Herth FJ, Noppen M, Valipour A, Leroy S, Vergnon JM, Ficker JH, et al.; International VENT Study Group. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012Jun;39(6):1334–42. 10.1183/09031936.00161611222825520903-1936 – reference: Koster TD, van Rikxoort EM, Huebner RH, Doellinger F, Klooster K, Charbonnier JP, et al.. Predicting Lung Volume Reduction after Endobronchial Valve Therapy Is Maximized Using a Combination of Diagnostic Tools. Respiration. 2016;92(3):150–7. 10.1159/000448849275771901423-0356 – reference: Gompelmann D, Lim HJ, Eberhardt R, Gerovasili V, Herth FJ, Heussel CP, et al.. Predictors of pneumothorax following endoscopic valve therapy in patients with severe emphysema. Int J Chron Obstruct Pulmon Dis. 2016Aug;11:1767–73. 10.2147/COPD.S106439275360881176-9106 – reference: Garner J, Kemp SV, Toma TP, Hansell DM, Polkey MI, Shah PL, et al.. Survival after Endobronchial Valve Placement for Emphysema: A 10-Year Follow-up Study. Am J Respir Crit Care Med. 2016Aug;194(4):519–21. 10.1164/rccm.201604-0852LE275254621073-449X – reference: Excellence NI. Endobronchial valve insertion to reduce lung volume in emphysema.nice.org.uk/guidance/ipg600, 2017. – reference: Darwiche K, Karpf-Wissel R, Eisenmann S, Aigner C, Welter S, Zarogoulidis P, et al.. Bronchoscopic Lung Volume Reduction with Endobronchial Valves in Low-FEV1 Patients. Respiration. 2016;92(6):414–9. 10.1159/000452629278386951423-0356 – reference: Mets OM, Smit EJ, Mohamed Hoesein FA, Gietema HA, Bokkers RP, Attrach M, et al.. Visual versus automated evaluation of chest computed tomography for the presence of chronic obstructive pulmonary disease. PLoS One. 2012;7(7):e42227. 10.1371/journal.pone.0042227228487471932-6203 – reference: Davey C, Zoumot Z, Jordan S, McNulty WH, Carr DH, Hind MD, et al.. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet. 2015Sep;386(9998):1066–73. 10.1016/S0140-6736(15)60001-0261164850140-6736 – reference: Valipour A, Slebos DJ, Herth F, Darwiche K, Wagner M, Ficker JH, et al.; IMPACT Study Team. Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study. Am J Respir Crit Care Med. 2016Nov;194(9):1073–82. 10.1164/rccm.201607-1383OC275804281073-449X – reference: Criner GD, Voelker K, et al. Endobronchial Valves for Severe Emphysema – 12-month Results of the EMPROVE Trial. Eur Respir J, 2018: p. OA 4928. – reference: Slebos DJ, Hartman JE, Klooster K, Blaas S, Deslee G, Gesierich W, et al.. Bronchoscopic Coil Treatment for Patients with Severe Emphysema: A Meta-Analysis. Respiration. 2015;90(2):136–45. 10.1159/000431384261123801423-0356 – reference: Shah PL, Gompelmann D, Valipour A, McNulty WH, Eberhardt R, Grah C, et al.. Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results. Lancet Respir Med. 2016Sep;4(9):e44–5. 10.1016/S2213-2600(16)30199-0274513452213-2600 – reference: Gompelmann D, Herth FJ, Slebos DJ, Valipour A, Ernst A, Criner GJ, et al.. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration. 2014;87(6):485–91. 10.1159/000360641248008141423-0356 – reference: Li S, Wang G, Wang C, Gao X, Jin F, Yang H, Han B, Zhou R, Chen C, Chen L, Bai C, Shen H, Herth FJF, Zhong N. The REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema. Respiration. DOI: 10.1159/000494327. Epub ahead of print. – reference: Eberhardt R, Gerovasili V, Kontogianni K, Gompelmann D, Ehlken N, Herth FJ, et al.. Endoscopic lung volume reduction with endobronchial valves in patients with severe emphysema and established pulmonary hypertension. Respiration. 2015;89(1):41–8. 10.1159/000368369255022351423-0356 – reference: Kemp SV. S.D., Kirk A., Kornaszewska M., Carron K., Ek L., Mal H., Pison V., Downer N.J., Broman N., Darwiche K., Rao J., Hubner R., Trosini-Desert V., Eberhardt R., Herth F.J.F., Derom E., Marquette C.H., A Multicenter, Prospective, Randomized, Controlled Trial of Endobronchial Valve Treatment vs Standard of Care in Heterogeneous Emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;195:A6740.1073-449X – reference: Gompelmann D, Benjamin N, Kontogianni K, Herth F, Heussel CP, Hoffmann H, et al.. Clinical and radiological outcome following pneumothorax after endoscopic lung volume reduction with valves. Int J Chron Obstruct Pulmon Dis. 2016Dec;11:3093–9. 10.2147/COPD.S117890279944481176-9106 – reference: Herth FJ, Slebos DJ, Rabe KF, Shah PL. Endoscopic Lung Volume Reduction: An Expert Panel Recommendation. Respiration. 2016;91(3):241–50. 10.1159/000444090269108451423-0356 – reference: Klooster K, ten Hacken NN, Slebos DJ. Endobronchial Valves for Emphysema. N Engl J Med. 2016Apr;374(14):1390.270502221533-4406 – reference: Valipour A, Slebos DJ, de Oliveira HG, Eberhardt R, Freitag L, Criner GJ, et al.. Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema—potential mechanisms, treatment algorithm, and case examples. Respiration. 2014;87(6):513–21. 10.1159/000360642247772921423-0356 – reference: Kontogianni K, Gerovasili V, Gompelmann D, Schuhmann M, Hoffmann H, Heussel CP, et al.. Coil therapy for patients with severe emphysema and bilateral incomplete fissures - effectiveness and complications after 1-year follow-up: a single-center experience. Int J Chron Obstruct Pulmon Dis. 2017Jan;12:383–94. 10.2147/COPD.S117655281769541176-9106 – reference: Welling JB, Hartman JE, Ten Hacken NH, Franz I, Charbonnier JP, van Rikxoort EM, et al.. Chartis Measurement of Collateral Ventilation: Conscious Sedation versus General Anesthesia - A Retrospective Comparison. Respiration. 2018;96(5):480–7. 10.1159/000490733301147071423-0356 – reference: Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, et al.; REVOLENS Study Group. Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial. JAMA. 2016Jan;315(2):175–84. 10.1001/jama.2015.17821267574660098-7484 – reference: Mets OM, de Jong PA, Prokop M. Computed tomographic screening for lung cancer: an opportunity to evaluate other diseases. JAMA. 2012Oct;308(14):1433–4. 10.1001/jama.2012.12656230473540098-7484 – reference: Labaki WW, Martinez CH, Martinez FJ, Galbán CJ, Ross BD, Washko GR, et al.. The Role of Chest Computed Tomography in the Evaluation and Management of the Patient with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017Dec;196(11):1372–9. 10.1164/rccm.201703-0451PP286616981073-449X – reference: Criner GJ, et al.. A Multicenter RCT of Zephyr(R) Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE). Am J Respir Crit Care Med. 2018. 10.1164/rccm.201803-0590OC1073-449X – reference: Marchetti N, Criner GJ. Surgical Approaches to Treating Emphysema: Lung Volume Reduction Surgery, Bullectomy, and Lung Transplantation. Semin Respir Crit Care Med. 2015Aug;36(4):592–608. 10.1055/s-0035-1556064262386441069-3424 – reference: Klooster K, Hartman JE, Ten Hacken NH, Slebos DJ. Improved Predictors of Survival after Endobronchial Valve Treatment in Patients with Severe Emphysema. Am J Respir Crit Care Med. 2017May;195(9):1272–4. 10.1164/rccm.201610-1993LE284593161073-449X – reference: van Geffen WH, Klooster K, Hartman JE, Ten Hacken NH, Kerstjens HA, Wolf RF, et al.. Pleural Adhesion Assessment as a Predictor for Pneumothorax after Endobronchial Valve Treatment. Respiration. 2017;94(2):224–31. 10.1159/000477258286370471423-0356 – reference: Fuehner T, Clajus C, Fuge J, Jonigk D, Welte T, Haverich A, et al.. Lung transplantation after endoscopic lung volume reduction. Respiration. 2015;90(3):243–50. 10.1159/000434685261380231423-0356 – reference: Hogg JC, Paré PD, Hackett TL. The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease. Physiol Rev. 2017Apr;97(2):529–52. 10.1152/physrev.00025.2015281514250031-9333 – reference: Herth FJ, Eberhardt R, Gompelmann D, Ficker JH, Wagner M, Ek L, et al.. Radiological and clinical outcomes of using Chartis™ to plan endobronchial valve treatment. Eur Respir J. 2013Feb;41(2):302–8. 10.1183/09031936.00015312225560250903-1936 – reference: Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group. Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial. JAMA. 2016 Jan 12;315(2):175–84. – reference: Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH, et al.; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010Sep;363(13):1233–44. 10.1056/NEJMoa0900928208605050028-4793 – reference: Herth FJ, Valipour A, Shah PL, Eberhardt R, Grah C, Egan J, et al.. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med. 2016Mar;4(3):185–93. 10.1016/S2213-2600(16)00045-X268993902213-2600 – reference: Klooster K, Ten Hacken NH, Franz I, Kerstjens HA, van Rikxoort EM, Slebos DJ. Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: a prospective feasibility trial. Respiration. 2014;88(2):116–25. 10.1159/000362522249029991423-0356 – reference: Wang G, S.l., Changhui W, Xinglin G, Faguang J, Huaping Y, Baohui H, Rui Z, Chengshui C, Liangan C, Chunxue B, Huahao S, Nanshan Z., Eur Respi J. The REACH study, a randomized controlled trial assessing the safety and effectiveness of the Spiration Valve System endobronchial therapy for severe emphysema: 12 month follow-up results., 2018. 50: p. OA 1465. – reference: Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013Aug;369(5):448–57. 10.1056/NEJMra1201534239024840028-4793 – reference: Shah PL, Zoumot Z, Singh S, Bicknell SR, Ross ET, Quiring J, et al.; RESET trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med. 2013May;1(3):233–40. 10.1016/S2213-2600(13)70047-X244291292213-2600 – reference: The Global Strategy for Diagnosis. Management and Prevention of COPD, updated2019. https://goldcopd.org/gold-reports/ – reference: Come CE, Kramer MR, Dransfield MT, Abu-Hijleh M, Berkowitz D, Bezzi M, et al.. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015Sep;46(3):651–62. 10.1183/09031936.00205614258370410903-1936 – reference: Halbert RJ, Natoli JL, Gano A, Badamgarav E, Buist AS, Mannino DM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006Sep;28(3):523–32. 10.1183/09031936.06.00124605166116540903-1936 – ident: ref27 doi: 10.1159/000360642 – ident: ref8 doi: 10.1159/000479379 – ident: ref26 doi: 10.2147/COPD.S106439 – ident: ref9 doi: 10.1159/000368369 – ident: ref12 doi: 10.1001/jama.2012.12656 – ident: ref11 doi: 10.1159/000448761 – ident: ref37 doi: 10.1016/S2213-2600(16)00045-X – ident: ref16 doi: 10.1183/09031936.00015312 – ident: ref22 doi: 10.1164/rccm.201803-0590OC – ident: ref4 doi: 10.1152/physrev.00025.2015 – ident: ref21 doi: 10.1016/S0140-6736(15)60001-0 – ident: ref24 doi: 10.1159/000360641 – ident: ref29 doi: 10.1159/000492274 – ident: ref15 doi: 10.1159/000448849 – ident: ref3 doi: 10.1164/rccm.201210-1843CI – ident: ref36 doi: 10.1001/jama.2016.6261 – ident: ref28 doi: 10.1164/rccm.201610-1993LE – ident: ref17 doi: 10.1159/000490733 – ident: ref41 doi: 10.1159/000322649 – ident: ref6 doi: 10.1183/09031936.06.00124605 – ident: ref31 doi: 10.1016/S2213-2600(13)70047-X – ident: ref2 doi: 10.1164/rccm.201701-0218PP – ident: ref5 doi: 10.1055/s-0035-1556064 – ident: ref13 doi: 10.1164/rccm.201703-0451PP – ident: ref38 doi: 10.1016/S2213-2600(16)30199-0 – ident: ref18 doi: 10.1056/NEJMoa0900928 – ident: ref19 doi: 10.1164/rccm.201607-1383OC – ident: ref34 doi: 10.1159/000431384 – ident: ref23 doi: 10.2147/COPD.S117890 – ident: ref20 doi: 10.1183/09031936.00161611 – ident: ref32 doi: 10.1159/000362522 – ident: ref42 doi: 10.1159/000434685 – ident: ref30 doi: 10.1164/rccm.201604-0852LE – ident: ref7 doi: 10.1159/000444090 – ident: ref33 doi: 10.2147/COPD.S117655 – ident: ref39 doi: 10.1183/09031936.00205614 – ident: ref1 doi: 10.1056/NEJMra1201534 – ident: ref14 doi: 10.1371/journal.pone.0042227 – ident: ref25 doi: 10.1159/000477258 – ident: ref35 doi: 10.1001/jama.2015.17821 – ident: ref40 doi: 10.1378/chest.12-0421 – ident: ref10 doi: 10.1159/000452629 |
| SSID | ssj0015882 |
| Score | 2.5247319 |
| Snippet | Endoscopic lung volume reduction (ELVR) therapies are gaining prominence as a treatment option with guideline recommendations by COPD GOLD and NICE and the... |
| SourceID | proquest pubmed crossref karger |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 548 |
| SubjectTerms | Interventional Pulmonology |
| Title | Endoscopic Lung Volume Reduction: An Expert Panel Recommendation – Update 2019 |
| URI | https://karger.com/doi/10.1159/000496122 https://www.ncbi.nlm.nih.gov/pubmed/30836374 https://www.proquest.com/docview/2188591886 |
| Volume | 97 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1423-0356 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0015882 issn: 0025-7931 databaseCode: BENPR dateStart: 19980101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection (NC LIVE) customDbUrl: eissn: 1423-0356 dateEnd: 20240930 omitProxy: true ssIdentifier: ssj0015882 issn: 0025-7931 databaseCode: 7X7 dateStart: 19980101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdZO0pfyj66LV1XtLHCwDjzR2Rbe8tCQghrKaUpeTO2JENp65jUgbGn_g_7D_eX7PRhxe1a2PbiBFmWbN3pdCfd_Q6hjzGHZaVQfjp-4PbjRMCUyjw3yeKCsIJxweSJ7tFxNJn1p3My73RuW15LqzrvsR8PxpX8D1WhDOgqo2T_gbK2USiA_0BfuAKF4fpXNB6VfCHDSi6Y8w0mrXOuRA0MGdeYsGbXT8EZ16AslkIi6cObXAuTS8lpnB1CZ1ZJ49-BpZq2NdZTcxbfOq-fCONWOBZXF98Ph8HhwJv2xr3WfmuuvfdAoF660zUDDlWsod6LX0qcR_Nsc_8crIIKvlxJrOWNikpu70vIUCi7L9HECUgwTCPjhRavoLy5XqihxBv5q_1zDZ-1hSnRGJxmXSYayPpPkU-o9pHsU9DWgnYdGOXqWtE-lCDcoc4HdA9fWz_2BG0GcRTJHBjx3JrsPkmSwCb9hW8x2FTQ52fb4zbaapq_o9w8vZS-_MvHTRelwpw9QzvG9sADzUjPUUeUL9DWkfGueIlO1vyEJT9hzU_Y8tMXPCix5iasuAnf5Sb86_Yn1nyEJbF20Ww8OhtOXJNxw2WgNtcuj5mgUUE8L_eLPPA5qPeg71FOGJGZgbw480OYxqHwqQiZD79ZFAaZX5CMU5qHr9BGuSjFG4T9SLAwiz3uC0-i6GW5OiQHdZZLCD7aRZ-aoUqZgaOXWVGuUmWWEpraAe6iD7ZqpTFYHqq0q8fbVmnK9--Vg2TTt9KKF130vqFOCoJVnpbB8C1WNynovhLbMUmiLnqtyWabaOi990inb9H2ekrso416uRLvQHmt8wPFXwdo8-vo-OT0N1okj1A |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endoscopic+Lung+Volume+Reduction%3A+An+Expert+Panel+Recommendation+%E2%80%93+Update+2019&rft.jtitle=Respiration&rft.au=Herth%2C+Felix%C2%A0J.F.&rft.au=Slebos%2C+Dirk-Jan&rft.au=Criner%2C+Gerard%C2%A0J.&rft.au=Valipour%2C+Arschang&rft.date=2019-01-01&rft.issn=0025-7931&rft.eissn=1423-0356&rft.volume=97&rft.issue=6&rft.spage=548&rft.epage=557&rft_id=info:doi/10.1159%2F000496122&rft_id=info%3Apmid%2F30836374&rft.externalDocID=496122 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0025-7931&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0025-7931&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0025-7931&client=summon |